Dr. Atibalentja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2019 - 2022
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2016 - 2019
University of California San Francisco School of MedicineClass of 2016
Publications & Presentations
PubMed
- 16 citationsAnti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy.Christina K Lee, Danielle F Atibalentja, Lilian E Yao, Jangho Park, Sibu Kuruvilla
Nanotheranostics. 2022-01-01 - 60 citationsThymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction.Danielle F. Atibalentja, Craig A. Byersdorfer, Emil R. Unanue
Journal of Immunology. 2009-12-15 - 57 citationsFunctional Redundancy between Thymic CD8α+ and Sirpα+ Conventional Dendritic Cells in Presentation of Blood-Derived Lysozyme by MHC Class II ProteinsDanielle F. Atibalentja, Kenneth M. Murphy, Emil R. Unanue
Journal of Immunology. 2011-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
